Search

Your search keyword '"Hogarty AN"' showing total 1,583 results

Search Constraints

Start Over You searched for: Author "Hogarty AN" Remove constraint Author: "Hogarty AN"
1,583 results on '"Hogarty AN"'

Search Results

101. Confirmatory Efficacy of Cognitive Enhancement Therapy for Early Schizophrenia: Results From a Multisite Randomized Trial

102. Twenty‐year perspective on blunt traumatic diaphragmatic injury in level 1 trauma centre: Early versus delayed diagnosis injury patterns and outcomes.

104. Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report

107. Inhibiting mitochondrial translation overcomes multidrug resistance in MYC-driven neuroblastoma via OMA1-mediated integrated stress response

109. Measuring Social and Psychological Outcomes from Activation Labour Market Programmes in Higher Education: A Pilot Study

110. Cognitive Enhancement Therapy for Adults with Autism Spectrum Disorder: Results of an 18-Month Feasibility Study

111. Review article: Early steroid administration for traumatic haemorrhagic shock: A systematic review.

115. Targeting CD38 in T-ALL Upregulates the Targetable Polyamine Metabolism Pathway

116. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

117. Smartphone use in ophthalmology: What is their place in clinical practice?

118. Brief Report: Is Cognitive Rehabilitation Needed in Verbal Adults with Autism? Insights from Initial Enrollment in a Trial of Cognitive Enhancement Therapy

119. HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy

120. Virulence of Beauveria sp. and Metarhizium sp. fungi towards Fall armyworm (Spodoptera frugiperda)

121. Response to letter to the editor regarding

122. Effects of Cognitive Enhancement Therapy on Employment Outcomes in Early Schizophrenia: Results from a 2-Year Randomized Trial

124. Survival of patients with neuroblastoma before versus after reduction of therapy due to the change in age cut-off from 12 to 18 months in Children’s Oncology Group (COG) risk stratification.

127. Supporting the Preparation of Beginning Teachers with Online Assessment Products

130. Laptop Computers in Teacher Preparation: Lessons Learned from the University of South Florida Implementation

131. Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma

132. Interval Estimates of Multivariate Effect Sizes: Coverage and Interval Width Estimates under Variance Heterogeneity and Nonnormality

133. Stage 4S Neuroblastoma

134. Targeting CD38 in T-ALL Upregulates the Targetable Polyamine Metabolism Pathway

135. Acute onset ocular myasthenia gravis after vaccination with the Oxford-AstraZeneca COVID-19 vaccine

136. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO):a randomised controlled trial

138. The Quality of Factor Solutions in Exploratory Factor Analysis: The Influence of Sample Size, Communality, and Overdetermination

139. Selection of Variables in Exploratory Factor Analysis: An Empirical Comparison of a Stepwise and Traditional Approach

144. Confirmatory Efficacy of Cognitive Enhancement Therapy for Early Schizophrenia: Results From a Multisite Randomized Trial

146. Another Look at Technology Use in Classrooms: The Development and Validation of an Instrument To Measure Teachers' Perceptions.

147. Cognitive enhancement therapy improves fronto-limbic regulation of emotion in alcohol and/or cannabis misusing schizophrenia: a preliminary study

148. Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma.

149. Association of heterogeneous MYCN amplification with clinical features, biological characteristics and outcomes in neuroblastoma: A report from the Children's Oncology Group

150. Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project

Catalog

Books, media, physical & digital resources